Charming Medical FY26 turns to net loss of US$22,648; revenue drops 22.7% to US$4.81 million

Charming Medical posted a net loss of US$22,648 for the year ended March 31, 2026, swinging from net income a year earlier.

Revenue fell 22.7% to US$4.81 million, driven by a 24.4% drop in beauty, wellness and postpartum services to US$4.51 million.

Operating loss was US$29,237, compared with operating income a year earlier, as professional fees jumped to US$782,448 on Nasdaq listing costs.

Cash and cash equivalents rose to US$4.7 million, while operating cash flow turned to an outflow of US$1.22 million.